
April 23 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O:
CONCERNED SHAREHOLDERS OF AURINIA PHARMACEUTICALS ANNOUNCE THEIR INTENTION TO WITHHOLD SUPPORT FOR CEO PETER GREENLEAF AT 2025 ANNUAL MEETING
MARKET CAPITAL AND LUCIEN SELCE: BELIEVE AURINIA SHAREHOLDERS WOULD BENEFIT FROM A LEANER, MORE ACCOUNTABLE BOARD